Compare CADL & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | IHRT |
|---|---|---|
| Founded | 1999 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 589.5M |
| IPO Year | 2021 | 2019 |
| Metric | CADL | IHRT |
|---|---|---|
| Price | $11.27 | $2.47 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | ★ $19.00 | $4.25 |
| AVG Volume (30 Days) | ★ 1.2M | 384.1K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | 54.19 |
| EPS | ★ N/A | N/A |
| Revenue | $125,000.00 | ★ $3,864,991,000.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.27 |
| 52 Week Low | $4.35 | $2.45 |
| 52 Week High | $14.00 | $6.56 |
| Indicator | CADL | IHRT |
|---|---|---|
| Relative Strength Index (RSI) | 43.88 | 36.46 |
| Support Level | $4.91 | $2.56 |
| Resistance Level | $11.36 | $2.90 |
| Average True Range (ATR) | 0.70 | 0.13 |
| MACD | -0.34 | 0.03 |
| Stochastic Oscillator | 31.85 | 20.29 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.